EUVIMEDEUVIMED entdecken
Crossref

Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy

A. Beerthuizen, T. Snellen, C. Drukker, A. Scholten, F. van Duijnhoven, M.J. Vrancken Peeters

European Journal of Cancer · 2026-03 · 237 · 116493

DOI: 10.1016/j.ejca.2026.116493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von A. Beerthuizen und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Beerthuizen, A., Snellen, T., Drukker, C., Scholten, A., Duijnhoven, F. V., & Peeters, M. V. (2026). Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy. European Journal of Cancer, 237, 116493. https://doi.org/10.1016/j.ejca.2026.116493

Vancouver

Beerthuizen A, Snellen T, Drukker C, Scholten A, Duijnhoven FV, Peeters MV. Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy. European Journal of Cancer. 2026;237:116493. doi:10.1016/j.ejca.2026.116493

BibTeX
@article{Beerthuizen2026,
  author = {Beerthuizen, A. and Snellen, T. and Drukker, C. and Scholten, A. and Duijnhoven, F. van and Peeters, M.J. Vrancken},
  title = {Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116493},
  doi = {10.1016/j.ejca.2026.116493}
}
Kostenlos starten →